Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Tissue factor pathway inhibitors].

Ewa Sierko1, Roman J Zawadzki, Marek Z Wojtukiewicz

  • 1Zakład Onkologii, Akademii Medycznej w Białymstoku.

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|October 5, 2002
PubMed
Summary

This study compares tissue factor pathway inhibitors (TFPI) and TFPI-2, highlighting their distinct roles in blood coagulation. Understanding these differences is crucial for hemostasis research and therapeutic development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-specific Orbital Inflammation of Sinonasal Origin.

Otolaryngologia polska = The Polish otolaryngology·2026
Same author

A Real-World, Single-Center, Observational Retrospective Experience of Durvalumab Treatment After Concomitant Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer.

Cancers·2026
Same author

Translating tumor epigenetic subtyping into methylome network-based prognostic models in early-stage NSCLC: results from the prospective MOBIT study.

Journal of translational medicine·2026
Same author

Prothrombotic Tendency in the Shadow of Cancer: Hypercoagulability, Impaired Clot Contraction and Fibrinolysis in Colorectal Cancer and Gastric Cancer Patients Undergoing Chemotherapy.

International journal of molecular sciences·2026
Same author

Thrombocytosis in cancer patients: when more is not better-in fact, the opposite.

Cancer metastasis reviews·2026
Same author

Standard of practice imaging vs. PET/MR: a comparative prospective study in rectal cancer staging.

International journal of colorectal disease·2025

Area of Science:

  • Biochemistry
  • Hematology

Context:

  • Blood coagulation is vital for hemostasis.
  • The extrinsic pathway is a key coagulation initiator.
  • Hemostasis is regulated by procoagulant factors and inhibitors.

Purpose:

  • To summarize existing data on tissue factor pathway inhibitors (TFPI) and TFPI-2.
  • To delineate the differences in synthesis, distribution, and mechanism of action between TFPI and TFPI-2.
  • To clarify the distinct inhibitory profiles of TFPI and TFPI-2.

Summary:

  • Tissue factor pathway inhibitor (TFPI) and TFPI-2 share structural similarities but differ significantly.
  • TFPI inhibits factor Xa and the tissue factor/factor VIIa complex.
  • TFPI-2 inhibits factor XIa, plasma kallikrein, plasmin, and trypsin, but not factor Xa.

Related Experiment Videos

Impact:

  • Provides a comprehensive overview of TFPI and TFPI-2.
  • Clarifies the specific roles of these inhibitors in regulating blood coagulation.
  • Informs future research on hemostasis and the development of anticoagulant therapies.